Showing results (281-290 of 375) with videos related to
Sort By:
Pageof 38
Hellenic Journal of Nuclear Medicine|November 17, 2011
Detection by (18)F-FDG PET of unsuspected extensive bone marrow metastases in a case of basosquamous carcinoma of the cheekPrathamesh Joshi, Mukta Joshi Kulkarni, Amit Abhyankar, et al.PET Clinics|May 10, 2016
The Role of PET and PET/CT in the Surgical Management of Breast Cancer: A ReviewSusan Bahl, Abass Alavi, Sandip Basu, et al.PET Clinics|August 14, 2018
Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current ApplicationDhritiman Chakraborty, Sandip Basu, Gary A Ulaner, et al.Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|July 7, 2017
Sarcoidosis Presenting with Tracheobronchial Calcification and Nodularity: An Unusual Case Presentation with Treatment Response Assessment by 18F-FDG-PET/CTSameer Bansal, Ketaki Utpat, Unnati Desai, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|February 9, 2025
Technetium-99m-labeled stealth liposomes: A new Strategy to Identify metastasis in tumour modelSwapna J Nabar, Tanuja Shet, Basant Malpani, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2014
Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocolDeepa Rani, Sushma Kaisar, Sushma Awasare, et al.Nuclear Medicine Communications|August 14, 2023
Exploratory analysis of 64 CuCl 2 PET-CT imaging in carcinoma prostate and its comparison with 68 Ga-PSMA-11 and 18 F-FDG PET-CTAamir K Nazar, Ashwini Kalshetty, Rubel Chakravarty, et al.Nuclear Medicine Communications|November 7, 2008
FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumorSandip Basu, Kunissery Mallath Mohandas, Harish Peshwe, et al.BMC Cancer|October 29, 2025
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Ameya D Puranik, Indraja D Dev, Sushil Yadav, et al.Clinical Microbiology Reviews|January 19, 2008
Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomographyRakesh Kumar, Sandip Basu, Drew Torigian, et al.Pageof 38